Stay updated on Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.

Latest updates to the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference2%
- Check27 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has been updated to reflect a new version of the research study, with the addition of collaborators and the removal of detailed study descriptions, including eligibility criteria and treatment protocols for head and neck cancer.SummaryDifference15%
Stay in the know with updates to Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.